Oral lysozyme can also reduce the metastasis of Lewis in mouse lung carcinoma (Sava et al., 1991), improving the efficacy of 5-FU on primary tumor growth and lung metastasis (Sava et al., 1995). Here, LYZ is linked to lung carcinoma.